In an eerie echo of last year’s national fungal meningitis outbreak, the US Food and Drug Administration warned Friday that an injectable steroid produced by a compounding pharmacy in Tennessee has caused problems for at least seven people.    

By Toni Clarke (Reuters) - The Food and Drug Administration said on Friday it has received seven reports of illnesses in patients who took steroid injections compounded by a pharmacy in Tennessee. The FDA said full clinical information about the patients is still being gathered, but it suggested some of the problems were infections and that "at least one of ...

(Reuters) - The Food and Drug Administration said on Friday it has received seven reports of negative reactions by patients who took steroid injections compounded by a pharmacy in Tennessee. The FDA said full clinical information about the patients is still being gathered but it suggested that at least some of the problems were caused by infections and "at least ...

WASHINGTON (MedPage Today) -- The FDA's push to gain more authority over large-scale compounding pharmacies like those at the center of last fall's fungal meningitis outbreak continues to gain opposition from House Republicans.

By Toni Clarke WASHINGTON (Reuters) - Representative Edward Markey, a Democrat from Massachusetts, on Thursday became the latest lawmaker to propose legislation that would give the U.S. Food and Drug Administration greater regulatory authority over drug compounding. U.S. lawmakers, responding to a deadly meningitis outbreak in 2012, continue to wrestle with ways to regulate the pharmacies that compound large volumes ...